Impact of Hemostasis on the Lymphatic System in Development and Disease.
Level 5 - mechanism / opinion, no new human data
Narrative review of biological and preclinical mechanisms without human clinical data or systematic review methods.
PubMed 37534465 · doi:10.1161/ATVBAHA.123.318824
What was done
This narrative review summarizes literature regarding the role of platelets and the broader hemostatic system in lymphatic network establishment, maturation, and function. The review highlights molecular interactions between lymphatic endothelial cells and platelets, specifically CLEC-2 (C-type lectin-like receptor-2) and PDPN (podoplanin).
What was found
The abstract reports no numerical values, patient counts, or effect estimates. It describes qualitative developmental and mechanistic findings: CLEC-2/PDPN interactions are required for separating embryonic lymph sacs from cardinal veins, genetic deficiency leads to blood-filled lymphatic vessels, CLEC-2/PDPN-dependent physiological thrombi prevent blood backflow at the thoracic duct-subclavian vein junction, and hemostasis regulates lymphangiogenesis during wound healing and inflammation.
Why it matters
Understanding the molecular interface between coagulation and lymphatic biology highlights hemostatic pathways as potential therapeutic targets for lymphatic disorders.
Limits
As a narrative review, the paper provides no systematic search protocol, statistical synthesis, or new clinical trial data. The described evidence is derived primarily from developmental biology and preclinical animal models, and clinical applicability in human lymphatic diseases remains to be demonstrated.
Cited by
- supports The left thoracic duct drains lymph from both legs, the torso, and the left upper body into the subclavian veins.